Ghost Tree Capital, LLC Xenon Pharmaceuticals Inc. Transaction History

Ghost Tree Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $2.94 Million - $3.42 Million	-86,049 Reduced 46.51%	98,951 $3.38 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $522,600 - $653,100	-15,000 Reduced 7.5%	185,000 $7.12 Million
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $6.69 Million - $8.07 Million	200,000 New	200,000 $7.16 Million
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $2.54 Million - $3.52 Million	-100,000 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$15.6 - $35.4 $10.8 Million - $24.4 Million	-690,000 Reduced 87.34%	100,000 $3.12 Million
Q3 2021 Nov 15, 2021	SELL	$14.86 - $19.45 $891,600 - $1.17 Million	-60,000 Reduced 7.06%	790,000 $12.1 Million
Q1 2021 May 14, 2021	BUY	$13.65 - $21.31 $2.05 Million - $3.2 Million	150,000 Added 21.43%	850,000 $15.2 Million
Q4 2020 Feb 16, 2021	BUY	$9.49 - $16.04 $3.56 Million - $6.02 Million	375,000 Added 115.38%	700,000 $10.8 Million
Q1 2020 May 15, 2020	BUY	$8.08 - $17.57 $2.63 Million - $5.71 Million	325,000 New	325,000 $3.69 Million

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.